Physician profile
Cuong P Ly
NPI 1306883053
$3,789.10
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $627 · 2020: $569 · 2021: $611 · 2022: $864 · 2023: $1,057 · 2024: $61.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,086 · Education: $33.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,085.66 |
| Education | $33.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $777.30 | 2019-2024 | Veltassa, Korsuva |
| Astrazeneca Pharmaceuticals LP | $709.03 | 2019-2023 | Farxiga, Lokelma |
| Otsuka America Pharmaceutical, INC. | $445.34 | 2019-2023 | Jynarque |
| Mallinckrodt Hospital Products INC. | $324.79 | 2020-2023 | Acthar |
| Opko Pharmaceuticals, LLC | $280.83 | 2019-2024 | Rayaldee |
| Akebia Therapeutics INC | $279.23 | 2019-2023 | Auryxia |
| Fresenius USA Marketing, INC. | $188.28 | 2019-2022 | |
| Horizon Therapeutics Plc | $164.20 | 2019-2023 | Krystexxa |
| Amgen INC. | $119.08 | 2019-2023 | Parsabiv |
| Calliditas Therapeutics US INC. | $99.22 | 2022-2023 | Tarpeyo |
| Novartis Pharmaceuticals Corporation | $82.33 | 2022-2024 | |
| Travere Therapeutics, INC. | $56.28 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $54.63 | 2022-2023 | |
| Mallinckrodt Enterprises LLC | $51.37 | 2019 | |
| Glaxosmithkline, LLC. | $40.33 | 2019-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $22.94 | 2021 | |
| Arbor Pharmaceuticals, INC. | $22.54 | 2020 | |
| Aurinia Pharma U.S., INC. | $21.54 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $20.04 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $16.19 | 2019 | |
| Boston Scientific Corporation | $13.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cuong Ly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.